cyclic peptides (University of California Irvine)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecyclic peptides (University of California Irvine)
Drug Alias NameTACE inhibitors (University of California Irvine)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of California Irvine
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A